79 related articles for article (PubMed ID: 8078199)
1. [Relation between HCV genotype and serum HCV RNA level as predictors of response to interferon-alfa 2b therapy in chronic hepatitis C].
Orito E; Mizokami M
Nihon Rinsho; 1994 Jul; 52(7):1754-8. PubMed ID: 8078199
[TBL] [Abstract][Full Text] [Related]
2. Biochemical and virological response of chronic hepatitis C after treatment with interferon-alpha for 6 or 12 months: predictors of sustained remission.
Papatheodoridis GV; Katsoulidou A; Touloumi G; Delladetsima JK; Hatzakis A; Tassopoulos NC
Eur J Gastroenterol Hepatol; 1996 May; 8(5):469-75. PubMed ID: 8804876
[TBL] [Abstract][Full Text] [Related]
3. Serum hepatitis C virus RNA levels in chronic hepatitis C--importance for outcome of interferon alfa-2b treatment.
Yun ZB; Reichard O; Chen M; Lundeberg J; Norkrans G; Fryden A; Sönnerborg A; Weiland O
Scand J Infect Dis; 1994; 26(3):263-70. PubMed ID: 7939425
[TBL] [Abstract][Full Text] [Related]
4. Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C.
Martinot-Peignoux M; Marcellin P; Pouteau M; Castelnau C; Boyer N; Poliquin M; Degott C; Descombes I; Le Breton V; Milotova V
Hepatology; 1995 Oct; 22(4 Pt 1):1050-6. PubMed ID: 7557850
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of simple assays for serum concentration of hepatitis C virus RNA and HCV genotype in predicting the response of patients with chronic hepatitis C to interferon alpha 2a therapy.
Suzuki T; Tanaka E; Matsumoto A; Urushihara A; Sodeyama T
J Med Virol; 1995 Jun; 46(2):162-8. PubMed ID: 7636506
[TBL] [Abstract][Full Text] [Related]
6. Serum hepatitis C virus RNA level as a predictor of subsequent response to interferon-alpha therapy in Japanese patients with chronic hepatitis C.
Orito E; Mizokami M; Nakano T; Terashima H; Nojiri O; Sakakibara K; Mizuno M; Ogino M; Nakamura M; Matsumoto Y
J Med Virol; 1994 Dec; 44(4):410-4. PubMed ID: 7897373
[TBL] [Abstract][Full Text] [Related]
7. Genotype, serum level of HCV-RNA and response to interferon-alpha treatment in patients with chronic hepatitis C.
Clarysse C; Van den Eynde C; Nevens F; Portier C; Aelbrecht N; Fevery J; Yap SH
Neth J Med; 1995 Dec; 47(6):265-71. PubMed ID: 8569931
[TBL] [Abstract][Full Text] [Related]
8. Patterns of hepatitis C viremia in patients receiving hemodialysis.
Umlauft F; Gruenewald K; Weiss G; Kessler H; Urbanek M; Haun M; Santner B; Koenig P; Keeffe EB
Am J Gastroenterol; 1997 Jan; 92(1):73-8. PubMed ID: 8995941
[TBL] [Abstract][Full Text] [Related]
9. Genotypes and titers of hepatitis C virus for predicting response to interferon in patients with chronic hepatitis C.
Hino K; Sainokami S; Shimoda K; Iino S; Wang Y; Okamoto H; Miyakawa Y; Mayumi M
J Med Virol; 1994 Mar; 42(3):299-305. PubMed ID: 7516422
[TBL] [Abstract][Full Text] [Related]
10. Treatment of chronic hepatitis C with interferon-alpha. Clinical histological and virological implications.
Olaso V; Córdoba J; Berenguer M; Prieto M; Lainez B; Argüello L; Valverde J; Pascual S; Gobernado M; Berenguer J
Rev Esp Enferm Dig; 1997 Jul; 89(7):531-50. PubMed ID: 9265839
[TBL] [Abstract][Full Text] [Related]
11. Predictive factors for efficacy of interferon therapy in chronic hepatitis type C.
Ishibashi K; Kashiwagi T; Ito A; Tanaka Y; Nagata T; Tamaki J; Azuma M; Kishida Y; Yoshida A; Hikiji AY
Hepatogastroenterology; 1995; 42(5):535-41. PubMed ID: 8751211
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of interferon alfa therapy in chronic hepatitis C patients depends primarily on hepatitis C virus RNA level.
Yamada G; Takatani M; Kishi F; Takahashi M; Doi T; Tsuji T; Shin S; Tanno M; Urdea MS; Kolberg JA
Hepatology; 1995 Nov; 22(5):1351-4. PubMed ID: 7590646
[TBL] [Abstract][Full Text] [Related]
13. Early loss of serum hepatitis C virus RNA can predict a sustained response to interferon therapy in patients with chronic hepatitis C.
Karino Y; Toyota J; Sugawara M; Higashino K; Sato T; Ohmura T; Suga T; Okuuchi Y; Matsushima T
Am J Gastroenterol; 1997 Jan; 92(1):61-5. PubMed ID: 8995939
[TBL] [Abstract][Full Text] [Related]
14. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection.
Enomoto N; Sakuma I; Asahina Y; Kurosaki M; Murakami T; Yamamoto C; Ogura Y; Izumi N; Marumo F; Sato C
N Engl J Med; 1996 Jan; 334(2):77-81. PubMed ID: 8531962
[TBL] [Abstract][Full Text] [Related]
15. Comparison of serum hepatitis C virus RNA concentration by branched DNA probe assay with competitive reverse transcription polymerase chain reaction as a predictor of response to interferon-alpha therapy in chronic hepatitis C patients.
Toyoda H; Nakano S; Kumada T; Takeda I; Sugiyama K; Osada T; Kiriyama S; Orito E; Mizokami M
J Med Virol; 1996 Apr; 48(4):354-9. PubMed ID: 8699168
[TBL] [Abstract][Full Text] [Related]
16. [HCV-serotype and IFN response].
Nakamura H; Kako M; Aikawa T; Mayumi M; Kanai K
Nihon Rinsho; 1994 Jul; 52(7):1734-7. PubMed ID: 7521412
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of human leucocyte alpha-interferon treatment for chronic hepatitis C virus infection.
Weiland O; Chen M; Lindh G; Mattsson L; Schvarcz R; Sönnerborg A; Wahl M; Wejstål R; Widell A; Norkrans G
Scand J Infect Dis; 1995; 27(5):319-24. PubMed ID: 8588128
[TBL] [Abstract][Full Text] [Related]
18. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C.
Lau JY; Davis GL; Kniffen J; Qian KP; Urdea MS; Chan CS; Mizokami M; Neuwald PD; Wilber JC
Lancet; 1993 Jun; 341(8859):1501-4. PubMed ID: 8099380
[TBL] [Abstract][Full Text] [Related]
19. Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus.
Misiani R; Bellavita P; Fenili D; Vicari O; Marchesi D; Sironi PL; Zilio P; Vernocchi A; Massazza M; Vendramin G
N Engl J Med; 1994 Mar; 330(11):751-6. PubMed ID: 8107741
[TBL] [Abstract][Full Text] [Related]
20. Quantitation and typing of serum hepatitis C virus RNA in patients with chronic hepatitis C treated with interferon-beta.
Kobayashi Y; Watanabe S; Konishi M; Yokoi M; Kakehashi R; Kaito M; Kondo M; Hayashi Y; Jomori T; Suzuki S
Hepatology; 1993 Dec; 18(6):1319-25. PubMed ID: 8244255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]